Home
BlogsMedia
Blogs
-
How Do You Know an Instrument Will Perform in Your Lab?
Independent Benchmark Study By Dr. Christian Fischer- Chief Scientific and Medical Officer AliveDx Clinical laboratories are operating under increasing pressure around growing test volumes, constrained staffing, and the need to deliver faster, more comprehensive diagnostic insight. At the same time, many systems are evaluated under controlled or optimized conditions that do not fully reflect how…
-
Vasculitis Diagnosis: Microarray Testing with MosaiQ AiPlex® VAS
What is Vasculitis? Vasculitis is a group of autoimmune disorders that cause inflammation of blood vessels, which can lead to organ and tissue damage. These disorders affect vessels of different sizes (small, medium, large) and may involve multiple organs such as kidneys and lungs, as well as the skin. Common forms include ANCA-associated vasculitis (AAV),…
-
Multiplex Microarray Testing for Connective Tissue Diseases
Key Takeaways What makes connective tissue diseases complex? Autoimmune connective tissue diseases (CTDs) are systemic autoimmune disorders affecting joints, muscles and vital organs. CTDs often present with overlapping symptoms, making clinical diagnosis challenging. Globally, autoimmune rheumatic diseases impact over 4% of the population [1][2] with conditions like systemic lupus erythematosus and Sjögren’s syndrome contributing to…
-
Celiac Disease Diagnostics and the Future of Autoimmune Testing
Celiac disease impacts approximately 0.7% (confirmed by biopsy) to 1.4% of the global population (based on positive results for celiac disease antibodies)[1] but despite advances in technology, it is largely underdiagnosed in the general population. Celiac disease is an autoimmune condition that is triggered by gluten ingestion which can lead to intestinal damage, malabsorption and…
-
Diabetes Diagnostics: The Need for Advanced Autoimmune Testing
The global impact of type 1 and type 2 diabetes Diabetes is one of the pressing health challenges of our time. According to the International Diabetes Federation (IDF)[1], 589 million adults worldwide are living with diabetes. This number is projected to rise to 853 million by 2050. Can type 1 and 2 diabetes be reversed?…
-
Unlock Lab Efficiencies with an AliveDx Evaluation
The global IVD market portfolio and associated technologies are constantly evolving. AliveDx utilizes innovative technology that provides more automation and multiplex testing to drive lab workflow efficiency. Our MosaiQ® and LumiQ® solutions are designed to help transform autoimmune and allergy diagnostics performance in clinical settings, supporting productivity gains, while driving cost efficiency in a laboratory…
-
Multiplexing: Streamline Autoimmune Testing with MosaiQ AiPlex® CTDplus
In the world of autoimmune diagnostics, time and accuracy are everything. Traditional serological testing often involves multiple assays, manual steps, and long turnaround times. AliveDx is changing that with the MosaiQ® AiPlex CTDplus, a fully automated multiplex microarray immunoassay designed to detect 15 autoantibodies in a single run. Why multiplex matters in autoimmune diagnostics Autoimmune…
-
How Machine Learning Is Transforming CTD Diagnosis
In-vitro diagnostics (IVD) is entering a new era, one where artificial intelligence (AI) and multiplexed immunoassays converge to deliver fast, smart and accurate results. At AliveDx, we’re proud to be at the forefront of this transformation with our MosaiQ® and LumiQ® instruments designed to help streamline lab workflows and transform patient care. In one of…
-
Transforming Vasculitis Diagnostics: Multiplex Microarray Solutions for PR3, MPO & GBM Autoantibodies
In–vitro diagnostics (IVD) is undergoing a transformation, driven by automation and a syndromic approach enabled by multiplexing technologies. At AliveDx, we’re proud to lead this evolution with the MosaiQ AiPlex® VAS microarray, a fully automated multiplex immunoassay designed to detect three critical autoantibodies: PR3, MPO, and GBM in a single, streamlined test. These markers…
-
Unlocking Comprehensive Insights in Autoimmune Diagnostics: The Role of Anti-DFS70 Autoantibodies
Autoimmune connective tissue diseases1 (CTD) such as lupus, Sjögren’s syndrome, and systemic sclerosis present a diagnostic challenge due to overlapping symptoms and complex antibody profiles. At AliveDx, we’re committed to the challenge of simplifying that complexity through innovative in-vitro diagnostic solutions that support the improvement of rapid disease detection and clinical decision making for fast…
